Some investors argue that massive share - price increases in 2014 mean that even future successes won't produce strong returns for shareholders buying in
at today's prices, but the
demand among top
pharmaceutical companies for promising drug candidates to add to their pipelines shows few signs of slowing anytime soon, and that could bode well for the sector in the coming year.
Investing in the health - care sectorA dynamic sector: From biotech to
pharmaceuticals, the fund seeks out
companies that profit from the global
demand for health care.A range of
companies: The fund invests worldwide in businesses
at different stages of growth, from rapidly growing newer
companies to established global corporations.Actively managed: Unlike passively managed ETFs, Putnam global sector funds combine rigorous fundamental research and disciplined quantitative analysis with macroeconomic views.